Should patient groups accept money from drug companies? No
AUTOR(ES)
Mintzes, Barbara
FONTE
BMJ Publishing Group Ltd.
RESUMO
Patient groups provide valuable support and advocacy for vulnerable people but funding the work can be difficult. Alastair Kent argues that not accepting industry money will unnecessarily limit the groups' effectiveness, but Barbara Mintzes believes that the money undermines their independence